LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

Search

West Pharmaceutical Services Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

274.87 0.98

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

269.97

Max

278.02

Pagrindiniai rodikliai

By Trading Economics

Pajamos

8.2M

140M

Pardavimai

38M

804M

P/E

Sektoriaus vid.

40.335

76.798

Pelnas, tenkantis vienai akcijai

1.96

Dividendų pajamingumas

0.31

Pelno marža

17.406

Darbuotojai

10,600

EBITDA

19M

217M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+27.94% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.31%

2.37%

Kitas dividendų mokėjimo data

2026-02-04

Kita Ex Dividend data

2026-01-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-209M

20B

Ankstesnė atidarymo kaina

273.89

Ankstesnė uždarymo kaina

274.87

Naujienos nuotaikos

By Acuity

50%

50%

166 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-22 23:54; UTC

Pagrindinės rinkos jėgos

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

2025-12-22 19:08; UTC

Įsigijimai, susijungimai, perėmimai

Correction to Alphabet to Buy Intersect Article

2025-12-22 17:21; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

2025-12-22 16:46; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion in Cash

2025-12-22 23:50; UTC

Rinkos pokalbiai

Nikkei May Decline as Yen Rebounds -- Market Talk

2025-12-22 23:42; UTC

Rinkos pokalbiai

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

2025-12-22 22:30; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

2025-12-22 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-22 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 21:37; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

2025-12-22 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Acquire Prospective Package From Tempest Minerals

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

2025-12-22 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Middle West Partners Buys Paul Stuart From Mitsui & Co.

2025-12-22 20:52; UTC

Įsigijimai, susijungimai, perėmimai

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

2025-12-22 20:09; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-12-22 19:56; UTC

Rinkos pokalbiai

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

2025-12-22 19:49; UTC

Įsigijimai, susijungimai, perėmimai

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

2025-12-22 19:23; UTC

Rinkos pokalbiai

Mexico's Inflation Seen Easing in Early December -- Market Talk

2025-12-22 19:23; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Precious Metals Climb to New Heights -- Market Talk

2025-12-22 18:45; UTC

Rinkos pokalbiai

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

2025-12-22 18:30; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

2025-12-22 18:23; UTC

Įsigijimai, susijungimai, perėmimai

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

2025-12-22 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-22 17:06; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Akcijų palyginimas

Kainos pokytis

West Pharmaceutical Services Inc Prognozė

Kainos tikslas

By TipRanks

27.94% į viršų

12 mėnesių prognozė

Vidutinis 348.7 USD  27.94%

Aukščiausias 375 USD

Žemiausias 285 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines West Pharmaceutical Services Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

10

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

213.26 / 219.27Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

166 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat